CTRI/2024/04/065583
Not yet recruiting
未知
Super Selective Intra - Arterial Chemotherapy for Retinoblastoma - A Prospective Comparative Study - NI
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Rajendra Prasad Centre for Ophthalmic Sciences
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with Group B/ Group C / Group D Retinoblastoma (International Classification),
- •Fit to undergo GA procedure, Informed Consent
Exclusion Criteria
- •Patients Diagnosed with Group A/ Group E Retinoblastoma (International Classification), Patients with Extraocular Spread / Systemic Metastasis, Patient/ LAR Not Willing for Treatment, Patient/ LAR Not Willing for Follow Up
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II study of induction chemotherapy using S-1 + intra-arterial cisplatin for locally advanced oral cancerJPRN-jRCTs041220065Shuichi Imaue29
Not yet recruiting
Not Applicable
Study of superselective intra-arterial chemotherapy using docetaxel and cisplatin and radiotherapy for advanced oral canceradvances oral cancerJPRN-UMIN000016047Yokohama City University Graduate School of Medicine100
Completed
Phase 2
Transcatheter arterial infusion chemotherapy using cisplatin powder and iodized-oil for advanced hepatocellular carcinoma: a phase 2 studyHCCJPRN-UMIN000005495Japan Society of Transcatheter Hepatic Arterial Embolization Clinical Reserch Group35
Completed
Not Applicable
Transcatheter arterial infusion chemotherapy using miriplatin in patients with advanced hepatocellular carcinoma: Prospective randomized study, Lip-TAI vs. Lip+DSM-TAIhepatocellular carcinomaJPRN-UMIN000004526Department of Gastroenterology and Hepatology, Yamaguchi Univercity Graduate School of Medicine100
Completed
Phase 3
Transarterial infusion chemotherapy using SMANCS with or without embolization in hepatocellular carcinoma: a randomised controlled multicenter phase III trialhepatocellular carcinomaJPRN-C000000111Research group for randomised study comparing transcatheter arterial chemoembolization to transarterial infusion chemotherapy160